Skip to content

Comparative Effectiveness of Ultrasound-Guided Liposomal Bupivacaine Intercostal Nerve Block versus Ultrasound-Guided Ropivacaine with Dexamethasone Paravertebral Nerve Block for Postoperative Analgesia Following NUSS Procedure in Pediatric Patients with Pectus Excavatum: A Prospective, Randomized Controlled Study

Comparative Effectiveness of Ultrasound-Guided Liposomal Bupivacaine Intercostal Nerve Block versus Ultrasound-Guided Ropivacaine with Dexamethasone Paravertebral Nerve Block for Postoperative Analgesia Following NUSS Procedure in Pediatric Patients with Pectus Excavatum: A Prospective, Randomized Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117839
Enrollment
Unknown
Registered
2026-01-29
Start date
2025-12-03
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain Following Pectus Excavatum Repair in Pediatric Patients

Interventions

Liposomal Bupivacaine Intercostal Nerve Block (ICB Group):The patient is placed in the lateral position. Usually, the 6th to 7th intercostal nerve is blocked, covering the upper and lower two rib spac
Ropivacaine with Dexamethasone Paravertebral Nerve Block Group (TPVB Group) :The patient was placed in the lateral position. The spinous process of the 5th thoracic vertebra was identified using ultr

Sponsors

West China Tianfu Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Age: 12 - 18 years old; 2. Elective for funnel chest NUSS surgery; 3. ASA: I - III grade; 4. Guardian signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Contraindications for regional nerve block (including coagulation disorders, allergy to local anesthetics, anatomical abnormalities, systemic infection, or infection at the injection site) 2. Guardian refusal or when the researcher deems it inappropriate to include in this study 3. Emergency surgery or reoperation patients 4. Postoperative ICU admission for continued supportive treatment 5. Already participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Mean NRS Resting Pain Score at 72 Hours Postoperatively Following NUSS Procedure for Pectus Excavatum;

Secondary

MeasureTime frame
Resting and Movement-Evoked NRS Pain Scores at 1, 12, 24, 48, and 72 Hours Postoperatively;Total Analgesic Consumption Within 24 and 48 Hours Postoperatively;Plasma Concentrations of Liposomal Bupivacaine at 10min, 30min, 60min, and 24h Post?injection;Time to First Request for Analgesia;Time to First Ambulation;Total Opioid Consumption via Patient-Controlled Analgesia (PCA) Pump and Number of PCA Demands;Total Analgesic Consumption Within 72 Hours;Length of Hospital Stay and Total Hospitalization Costs;

Countries

China

Contacts

Public ContactDongjiao Wu

Sichuan University West China Tianfu Hospital

961959366@qq.com+86 28 6066 0475

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026